ERCC1 as a marker of prognosis and sensitivity to platinum-based chemotherapy in patients with stage III–IV non-small cell lung cancer
Author(s) -
О. П. Колеснік,
V. A. Kuz’menko
Publication year - 2020
Publication title -
pathologia
Language(s) - English
Resource type - Journals
eISSN - 2310-1237
pISSN - 2306-8027
DOI - 10.14739/2310-1237.2020.1.203639
Subject(s) - ercc1 , lung cancer , medicine , oncology , chemotherapy , stage (stratigraphy) , clinical significance , immunohistochemistry , biology , paleontology , biochemistry , nucleotide excision repair , dna repair , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom